Cargando…

A new strategy for faster urinary biomarkers identification by Nano-LC-MALDI-TOF/TOF mass spectrometry

BACKGROUND: LC-MALDI-TOF/TOF analysis is a potent tool in biomarkers discovery characterized by its high sensitivity and high throughput capacity. However, methods based on MALDI-TOF/TOF for biomarkers discovery still need optimization, in particular to reduce analysis time and to evaluate their rep...

Descripción completa

Detalles Bibliográficos
Autores principales: Benkali, K, Marquet, P, Rérolle, JP, Le Meur, Y, Gastinel, LN
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2596142/
https://www.ncbi.nlm.nih.gov/pubmed/19014585
http://dx.doi.org/10.1186/1471-2164-9-541
_version_ 1782161828670865408
author Benkali, K
Marquet, P
Rérolle, JP
Le Meur, Y
Gastinel, LN
author_facet Benkali, K
Marquet, P
Rérolle, JP
Le Meur, Y
Gastinel, LN
author_sort Benkali, K
collection PubMed
description BACKGROUND: LC-MALDI-TOF/TOF analysis is a potent tool in biomarkers discovery characterized by its high sensitivity and high throughput capacity. However, methods based on MALDI-TOF/TOF for biomarkers discovery still need optimization, in particular to reduce analysis time and to evaluate their reproducibility for peak intensities measurement. The aims of this methodological study were: (i) to optimize and critically evaluate each step of urine biomarker discovery method based on Nano-LC coupled off-line to MALDI-TOF/TOF, taking full advantage of the dual decoupling between Nano-LC, MS and MS/MS to reduce the overall analysis time; (ii) to evaluate the quantitative performance and reproducibility of nano-LC-MALDI analysis in biomarker discovery; and (iii) to evaluate the robustness of biomarkers selection. RESULTS: A pool of urine sample spiked at increasing concentrations with a mixture of standard peptides was used as a specimen for biological samples with or without biomarkers. Extraction and nano-LC-MS variabilities were estimated by analyzing in triplicates and hexaplicates, respectively. The stability of chromatographic fractions immobilised with MALDI matrix on MALDI plates was evaluated by successive MS acquisitions after different storage times at different temperatures. Low coefficient of variation (CV%: 10–22%) and high correlation (R(2 )> 0.96) values were obtained for the quantification of the spiked peptides, allowing quantification of these peptides in the low fentomole range, correct group discrimination and selection of "specific" markers using principal component analysis. Excellent peptide integrity and stable signal intensity were found when MALDI plates were stored for periods of up to 2 months at +4°C. This allowed storage of MALDI plates between LC separation and MS acquisition (first decoupling), and between MS and MSMS acquisitions while the selection of inter-group discriminative ions is done (second decoupling). Finally the recording of MSMS spectra to obtain structural information was focused only on discriminative ions in order to minimize analysis time. CONCLUSION: Contrary to other classical approaches with direct online coupling of chromatographic separation and on the flight MS and/or MSMS data acquisition for all detected analytes, our dual decoupling strategy allowed us to focus on the most discriminative analytes, giving us more time to acquire more replicates of the same urine samples thus increasing detection sensitivity and mass precision.
format Text
id pubmed-2596142
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-25961422008-12-05 A new strategy for faster urinary biomarkers identification by Nano-LC-MALDI-TOF/TOF mass spectrometry Benkali, K Marquet, P Rérolle, JP Le Meur, Y Gastinel, LN BMC Genomics Methodology Article BACKGROUND: LC-MALDI-TOF/TOF analysis is a potent tool in biomarkers discovery characterized by its high sensitivity and high throughput capacity. However, methods based on MALDI-TOF/TOF for biomarkers discovery still need optimization, in particular to reduce analysis time and to evaluate their reproducibility for peak intensities measurement. The aims of this methodological study were: (i) to optimize and critically evaluate each step of urine biomarker discovery method based on Nano-LC coupled off-line to MALDI-TOF/TOF, taking full advantage of the dual decoupling between Nano-LC, MS and MS/MS to reduce the overall analysis time; (ii) to evaluate the quantitative performance and reproducibility of nano-LC-MALDI analysis in biomarker discovery; and (iii) to evaluate the robustness of biomarkers selection. RESULTS: A pool of urine sample spiked at increasing concentrations with a mixture of standard peptides was used as a specimen for biological samples with or without biomarkers. Extraction and nano-LC-MS variabilities were estimated by analyzing in triplicates and hexaplicates, respectively. The stability of chromatographic fractions immobilised with MALDI matrix on MALDI plates was evaluated by successive MS acquisitions after different storage times at different temperatures. Low coefficient of variation (CV%: 10–22%) and high correlation (R(2 )> 0.96) values were obtained for the quantification of the spiked peptides, allowing quantification of these peptides in the low fentomole range, correct group discrimination and selection of "specific" markers using principal component analysis. Excellent peptide integrity and stable signal intensity were found when MALDI plates were stored for periods of up to 2 months at +4°C. This allowed storage of MALDI plates between LC separation and MS acquisition (first decoupling), and between MS and MSMS acquisitions while the selection of inter-group discriminative ions is done (second decoupling). Finally the recording of MSMS spectra to obtain structural information was focused only on discriminative ions in order to minimize analysis time. CONCLUSION: Contrary to other classical approaches with direct online coupling of chromatographic separation and on the flight MS and/or MSMS data acquisition for all detected analytes, our dual decoupling strategy allowed us to focus on the most discriminative analytes, giving us more time to acquire more replicates of the same urine samples thus increasing detection sensitivity and mass precision. BioMed Central 2008-11-14 /pmc/articles/PMC2596142/ /pubmed/19014585 http://dx.doi.org/10.1186/1471-2164-9-541 Text en Copyright © 2008 Benkali et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Methodology Article
Benkali, K
Marquet, P
Rérolle, JP
Le Meur, Y
Gastinel, LN
A new strategy for faster urinary biomarkers identification by Nano-LC-MALDI-TOF/TOF mass spectrometry
title A new strategy for faster urinary biomarkers identification by Nano-LC-MALDI-TOF/TOF mass spectrometry
title_full A new strategy for faster urinary biomarkers identification by Nano-LC-MALDI-TOF/TOF mass spectrometry
title_fullStr A new strategy for faster urinary biomarkers identification by Nano-LC-MALDI-TOF/TOF mass spectrometry
title_full_unstemmed A new strategy for faster urinary biomarkers identification by Nano-LC-MALDI-TOF/TOF mass spectrometry
title_short A new strategy for faster urinary biomarkers identification by Nano-LC-MALDI-TOF/TOF mass spectrometry
title_sort new strategy for faster urinary biomarkers identification by nano-lc-maldi-tof/tof mass spectrometry
topic Methodology Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2596142/
https://www.ncbi.nlm.nih.gov/pubmed/19014585
http://dx.doi.org/10.1186/1471-2164-9-541
work_keys_str_mv AT benkalik anewstrategyforfasterurinarybiomarkersidentificationbynanolcmalditoftofmassspectrometry
AT marquetp anewstrategyforfasterurinarybiomarkersidentificationbynanolcmalditoftofmassspectrometry
AT rerollejp anewstrategyforfasterurinarybiomarkersidentificationbynanolcmalditoftofmassspectrometry
AT lemeury anewstrategyforfasterurinarybiomarkersidentificationbynanolcmalditoftofmassspectrometry
AT gastinelln anewstrategyforfasterurinarybiomarkersidentificationbynanolcmalditoftofmassspectrometry
AT benkalik newstrategyforfasterurinarybiomarkersidentificationbynanolcmalditoftofmassspectrometry
AT marquetp newstrategyforfasterurinarybiomarkersidentificationbynanolcmalditoftofmassspectrometry
AT rerollejp newstrategyforfasterurinarybiomarkersidentificationbynanolcmalditoftofmassspectrometry
AT lemeury newstrategyforfasterurinarybiomarkersidentificationbynanolcmalditoftofmassspectrometry
AT gastinelln newstrategyforfasterurinarybiomarkersidentificationbynanolcmalditoftofmassspectrometry